447 related articles for article (PubMed ID: 33227233)
1. Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing.
Loh TP; Lord SJ; Bell K; Bohn MK; Lim CY; Markus C; Fares Taie H; Adeli K; Lippi G; Sandberg S; Horvath A
Clin Biochem; 2021 Feb; 88():18-22. PubMed ID: 33227233
[TBL] [Abstract][Full Text] [Related]
2. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
[TBL] [Abstract][Full Text] [Related]
3. Routine laboratory testing to determine if a patient has COVID-19.
Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
[TBL] [Abstract][Full Text] [Related]
4. Designing and Interpreting Coronavirus Disease 2019 (COVID-19) Diagnostics: Mathematics, Visual Logistics, and Low Prevalence.
Kost GJ
Arch Pathol Lab Med; 2021 Mar; 145(3):291-307. PubMed ID: 32906146
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Increasing Disease Prevalence, False Omissions, and Diagnostic Uncertainty on Coronavirus Disease 2019 (COVID-19) Test Performance.
Kost GJ
Arch Pathol Lab Med; 2021 Jul; 145(7):797-813. PubMed ID: 33684204
[TBL] [Abstract][Full Text] [Related]
6. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
[TBL] [Abstract][Full Text] [Related]
7. Bounding the Accuracy of Diagnostic Tests, With Application to COVID-19 Antibody Tests.
Manski CF
Epidemiology; 2021 Mar; 32(2):162-167. PubMed ID: 33394811
[TBL] [Abstract][Full Text] [Related]
8. Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses - Wisconsin, September-October 2020.
Pray IW; Ford L; Cole D; Lee C; Bigouette JP; Abedi GR; Bushman D; Delahoy MJ; Currie D; Cherney B; Kirby M; Fajardo G; Caudill M; Langolf K; Kahrs J; Kelly P; Pitts C; Lim A; Aulik N; Tamin A; Harcourt JL; Queen K; Zhang J; Whitaker B; Browne H; Medrzycki M; Shewmaker P; Folster J; Bankamp B; Bowen MD; Thornburg NJ; Goffard K; Limbago B; Bateman A; Tate JE; Gieryn D; Kirking HL; Westergaard R; Killerby M;
MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1642-1647. PubMed ID: 33382679
[TBL] [Abstract][Full Text] [Related]
9. Scaling up COVID-19 rapid antigen tests: promises and challenges.
Peeling RW; Olliaro PL; Boeras DI; Fongwen N
Lancet Infect Dis; 2021 Sep; 21(9):e290-e295. PubMed ID: 33636148
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
[TBL] [Abstract][Full Text] [Related]
11. Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting.
Skittrall JP; Wilson M; Smielewska AA; Parmar S; Fortune MD; Sparkes D; Curran MD; Zhang H; Jalal H
Clin Microbiol Infect; 2021 Mar; 27(3):469.e9-469.e15. PubMed ID: 33068757
[TBL] [Abstract][Full Text] [Related]
12. [Antibody tests for COVID-19: What the results tell us].
Horvath K; Semlitsch T; Jeitler K; Krause R; Siebenhofer A
Z Evid Fortbild Qual Gesundhwes; 2020 Aug; 153():54-59. PubMed ID: 32419875
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of RNA Extraction-Free Method for Detection of SARS-CoV-2 in Salivary Samples for Mass Screening for COVID-19.
Mahmoud SA; Ganesan S; Ibrahim E; Thakre B; Teddy JG; Raheja P; Abbas WZ
Biomed Res Int; 2021; 2021():5568350. PubMed ID: 34327228
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Abbott BinaxNOW COVID-19 Test Ag Card for rapid detection of SARS-CoV-2 infection by a local public health district with a rural population.
Pollreis RE; Roscoe C; Phinney RJ; Malesha SS; Burns MC; Ceniseros A; Washington CH; Nutting AJ; Ball CL
PLoS One; 2021; 16(12):e0260862. PubMed ID: 34855887
[TBL] [Abstract][Full Text] [Related]
16. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
17. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.
Parry JV; Easterbrook P; Sands AR
BMC Infect Dis; 2017 Nov; 17(Suppl 1):705. PubMed ID: 29143611
[TBL] [Abstract][Full Text] [Related]
18. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
[TBL] [Abstract][Full Text] [Related]
19. The risk of over-diagnosis in serological testing. Implications for communications strategies.
Biggeri A; Forni S; Braga M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):184-192. PubMed ID: 33412809
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 diagnostic tests: importance of the clinical context.
Vila Muntadas M; Agustí Sunyer I; Agustí Garcia-Navarro A
Med Clin (Barc); 2021 Aug; 157(4):185-190. PubMed ID: 34158178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
